| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 18.746 | 41.210 | 55.021 | 40.338 | 69.616 | 94.031 | 132.342 | 122.324 |
| Total Income - EUR | - | - | 18.838 | 41.210 | 55.021 | 40.338 | 69.616 | 94.031 | 132.352 | 122.567 |
| Total Expenses - EUR | - | - | 2.628 | 11.058 | 10.217 | 5.288 | 14.538 | 18.487 | 22.521 | 28.054 |
| Gross Profit/Loss - EUR | - | - | 16.211 | 30.153 | 44.805 | 35.050 | 55.079 | 75.545 | 109.832 | 94.514 |
| Net Profit/Loss - EUR | - | - | 15.645 | 28.917 | 43.224 | 33.932 | 53.558 | 74.624 | 108.535 | 91.278 |
| Employees | - | - | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Gynoprof S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 1.023 | 5.051 | 3.819 | 1.901 | 1.124 | 5.378 | 7.059 | 7.526 |
| Current Assets | - | - | 15.072 | 34.844 | 47.607 | 44.712 | 53.570 | 69.912 | 103.935 | 91.405 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| Receivables | - | - | 2.063 | 9.663 | 13.069 | 3.069 | 12.444 | 59.759 | 80.145 | 70.459 |
| Cash | - | - | 13.009 | 25.181 | 34.537 | 41.643 | 41.127 | 10.153 | 23.789 | 20.946 |
| Shareholders Funds | - | - | 15.689 | 39.805 | 50.733 | 45.457 | 53.607 | 74.536 | 108.583 | 93.107 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 406 | 90 | 693 | 1.155 | 1.088 | 755 | 2.671 | 5.852 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Gynoprof S.r.l.